Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Oct 1;12(5):746-751.
doi: 10.21037/hbsn-23-319. Epub 2023 Sep 13.

AASLD practice guidance on drug, herbal, and dietary supplement-induced liver injury: also useful for hepatobiliary surgeons

Jose María Pinazo-Bandera  1   2 , Miren García-Cortés  1   2 , Raúl J Andrade  1   2
Affiliations
Editorial

AASLD practice guidance on drug, herbal, and dietary supplement-induced liver injury: also useful for hepatobiliary surgeons

Jose María Pinazo-Bandera et al. Hepatobiliary Surg Nutr. .
No abstract available

Keywords: Drug-induced liver injury (DILI); Revised Electronic Causality Assessment Method (RECAM); causality assessment; hepatotoxicity.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://hbsn.amegroups.com/article/view/10.21037/hbsn-23-319/coif). The authors have no conflicts of interest to declare.

Figures

Figure 1
Figure 1
DILI diagnostic algorithm. AST, aspartate aminotransferase; ALT, alanine aminotransferase; ULN, upper limit of normal; ALP, alkaline phosphatase; TB, total bilirubin; INR, international normalized ratio; HDS, herbal and dietary supplement; RUCAM, Roussel-Uclaf Causality Assessment Method; RECAM, Revised Electronic Causality Assessment Method; HAV, hepatitis A virus; IgM, immunoglobulin M; HCV, hepatitis C virus; HEV, hepatitis E virus; PCR, polymerase chain reaction; EBV, Epstein-Barr virus; CMV, cytomegalovirus; HSV, herpes simplex virus; ANA, antinuclear antibody; ASMA, anti-smooth muscle antibody; Anti-LKM1, anti-liver/kidney microsomal antibody type 1; IgG, immunoglobulin G; PEth, phosphatidylethanol; AT, antitrypsin; NAFLD, non-alcoholic fatty liver disease; US, ultrasound; MRI, magnetic resonance imaging; CT, computerized tomography; AMA, anti-mitochondrial antibody; MRC, magnetic resonance cholangiography; GGT, LDH, lactate dehydrogenase; TPN, total parenteral nutrition.
See this image and copyright information in PMC

Comment on

References

    1. European Association for the Study of the Liver . Electronic address: easloffice@easloffice.eu; Clinical Practice Guideline Panel: Chair:; Panel members; EASL Governing Board representative:. EASL Clinical Practice Guidelines: Drug-induced liver injury. J Hepatol 2019;70:1222-61. 10.1016/j.jhep.2019.02.014 - DOI - PubMed
    1. Devarbhavi H, Aithal G, Treeprasertsuk S, et al. Drug-induced liver injury: Asia Pacific Association of Study of Liver consensus guidelines. Hepatol Int 2021;15:258-82. 10.1007/s12072-021-10144-3 - DOI - PubMed
    1. Chalasani NP, Maddur H, Russo MW, et al. ACG Clinical Guideline: Diagnosis and Management of Idiosyncratic Drug-Induced Liver Injury. Am J Gastroenterol 2021;116:878-98. 10.14309/ajg.0000000000001259 - DOI - PubMed
    1. Fontana RJ, Liou I, Reuben A, et al. AASLD practice guidance on drug, herbal, and dietary supplement-induced liver injury. Hepatology 2023;77:1036-65. 10.1002/hep.32689 - DOI - PMC - PubMed
    1. Andrade RJ, Chalasani N, Björnsson ES, et al. Drug-induced liver injury. Nat Rev Dis Primers 2019;5:58. 10.1038/s41572-019-0105-0 - DOI - PubMed